Severe Relapsing Goodpasture's Disease Successfully Treated with Mycophenolate Mofetil

Area of Science:

• Nephrology
• Immunology
• Pulmonology

Background:

• Goodpasture's disease is a rare autoimmune disorder causing kidney and lung damage.
• It involves autoantibodies attacking the glomerular basement membrane, leading to glomerulonephritis and pulmonary hemorrhage.
• Conventional treatments like immunosuppression and plasma exchange have high mortality rates.

Observation:

• A patient with severe, relapsing Goodpasture's disease experienced pulmonary hemorrhage unresponsive to standard therapies.
• The patient was treated with mycophenolate mofetil (MMF) and prednisolone as a second-line approach.
• The prescribed low-dose MMF regimen proved insufficient for managing the refractory disease.

Findings:

• This case highlights the potential inadequacy of standard MMF dosing in severe, relapsing Goodpasture's disease.
• Higher doses of mycophenolate mofetil may be a viable alternative treatment option.
• The study suggests MMF's mechanism of action could be beneficial in relapsing cases.

Implications:

• Increased MMF dosage should be considered for patients with relapsing Goodpasture's disease.
• This approach may offer a more effective therapeutic strategy given limited treatment options.
• Further research into optimal MMF dosing for Goodpasture's disease is warranted.